VRCAVerrica Pharmaceuticals Inc.
4.820USD-3.41%Mkt Cap: 82.80M $P/E: —3d ago
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap82.80M $
Enterprise Value74.10M $
Revenue (TTM)30.32M $
Gross Profit32.14M $
Net Income (TTM)-17.89M $
Revenue/Share1.831 USD
Last Price4.820 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees76
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS92511W1080
Valuation
P/E (Trailing)—
P/E (Forward)-3.30
PEG—
EV/EBITDA-2.85
EV/Revenue2.44
P/S2.75
P/B19.36
EPS (TTM)-1.69
EPS (Forward)-1.47
52W Range
3.28024% of range9.821
52W High9.821 USD
52W Low3.280 USD
Profitability
Gross Margin90.33%
Oper. Margin-194.46%
EBITDA Margin-85.63%
Profit Margin-50.27%
ROE-72.29%
ROA-37.95%
Growth
Revenue Growth-53.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.63M $
CapEx (TTM)—
FCF Margin-29.80%
FCF Yield-10.91%
Net Debt-9.39M $
Net Debt/EBITDA0.36
Balance Sheet
Debt/Equity0.07
Current Ratio1.45
Quick Ratio0.99
Book Value/Sh0.2510 USD
Cash/Share0.6520 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 25, 2025
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)14.80 USD
Upside (mean)+207.1%
Target Range10.00 USD – 20.00 USD
$10.00+207.1% to mean$20.00
# Analysts5
Ownership
Shares Out.17.18M
Float7.90M
Insiders49.00%
Institutions27.14%
Short Interest
Short Ratio9.7d
Short % Float3.26%
Short % Out.1.68%
Shares Short287.75K
Short (prev mo.)324.68K
Technical
SMA 505.614 (-14.1%)
SMA 2006.171 (-21.9%)
Beta1.49
S&P 52W Chg18.16%
Avg Vol (30d)46.90K
Avg Vol (10d)91.15K
Technical Indicators
RSI (14)38.1
MACD-0.2166
MACD Signal-0.2024
MACD Hist.-0.0142
BB Upper5.581 USD
BB Middle5.172 USD
BB Lower4.763 USD
BB Width15.83%
ATR (14)0.4225 USD
Vol Ratio (20d)1.39x